Kezar Life Sciences Receives $23,000,000 Series A Financing

  • Feed Type
  • Date
    6/18/2015
  • Company Name
    Kezar Life Sciences
  • Mailing Address
    300 Utah Avenue South San Francisco, CA 94080 USA
  • Company Description
    Kezar Life Sciences, a privately held company based in South San Francisco, was founded in 2015 to develop drugs to revolutionize the treatment of autoimmune disorders.
  • Website
    http://www.kezarbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The capital raised in the Series A will be used to advance Kezar’s lead immunoproteasome inhibitor candidate into Phase 1a and 1b clinical trials, with the goal of demonstrating safety and efficacy in patients with autoimmune disease.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy